156 related articles for article (PubMed ID: 32870824)
1. Atorvastatin Enhances Effects of Radiotherapy on Prostate Cancer Cells and Xenograft Tumor Mice Through Triggering Interaction Between Bcl-2 and MSH2.
He Z; Yuan J; Shen F; Zeng F; Qi P; Wang Z; Zhai Z
Med Sci Monit; 2020 Sep; 26():e923560. PubMed ID: 32870824
[TBL] [Abstract][Full Text] [Related]
2. Atorvastatin Enhances Inhibitory Effects of Irradiation on Tumor Growth by Reducing MSH2 Expression Both in Prostate Cancer Cells and Xenograft Tumor Models.
He Z; Xu D; Shen F; Zeng F; Qi P; Zhai Z; Wang Z
Anticancer Agents Med Chem; 2022; 22(7):1328-1339. PubMed ID: 34080969
[TBL] [Abstract][Full Text] [Related]
3. Bcl-2 family inhibition sensitizes human prostate cancer cells to docetaxel and promotes unexpected apoptosis under caspase-9 inhibition.
Tamaki H; Harashima N; Hiraki M; Arichi N; Nishimura N; Shiina H; Naora K; Harada M
Oncotarget; 2014 Nov; 5(22):11399-412. PubMed ID: 25333266
[TBL] [Abstract][Full Text] [Related]
4. Atorvastatin regulates the migration and invasion of prostate cancer through the epithelial-mesenchymal transformation and matrix metalloproteinase pathways.
Zhu Z; Cao Y; Liu L; Zhao Z; Yin H; Wang H
Investig Clin Urol; 2022 May; 63(3):350-358. PubMed ID: 35534220
[TBL] [Abstract][Full Text] [Related]
5. Mechanistic Study of Inhibitory Effects of Metformin and Atorvastatin in Combination on Prostate Cancer Cells in Vitro and in Vivo.
Wang ZS; Huang HR; Zhang LY; Kim S; He Y; Li DL; Farischon C; Zhang K; Zheng X; Du ZY; Goodin S
Biol Pharm Bull; 2017; 40(8):1247-1254. PubMed ID: 28769006
[TBL] [Abstract][Full Text] [Related]
6. Docetaxel induces Bcl-2- and pro-apoptotic caspase-independent death of human prostate cancer DU145 cells.
Ogura T; Tanaka Y; Tamaki H; Harada M
Int J Oncol; 2016 Jun; 48(6):2330-8. PubMed ID: 27082738
[TBL] [Abstract][Full Text] [Related]
7. Galiellalactone is a novel therapeutic candidate against hormone-refractory prostate cancer expressing activated Stat3.
Hellsten R; Johansson M; Dahlman A; Dizeyi N; Sterner O; Bjartell A
Prostate; 2008 Feb; 68(3):269-80. PubMed ID: 18163422
[TBL] [Abstract][Full Text] [Related]
8. Ionizing radiation enhances the therapeutic potential of TRAIL in prostate cancer in vitro and in vivo: Intracellular mechanisms.
Shankar S; Singh TR; Srivastava RK
Prostate; 2004 Sep; 61(1):35-49. PubMed ID: 15287092
[TBL] [Abstract][Full Text] [Related]
9. Anticancer efficacy of simvastatin on prostate cancer cells and tumor xenografts is associated with inhibition of Akt and reduced prostate-specific antigen expression.
Kochuparambil ST; Al-Husein B; Goc A; Soliman S; Somanath PR
J Pharmacol Exp Ther; 2011 Feb; 336(2):496-505. PubMed ID: 21059805
[TBL] [Abstract][Full Text] [Related]
10. Preclinical evaluation of sunitinib, a multi-tyrosine kinase inhibitor, as a radiosensitizer for human prostate cancer.
Brooks C; Sheu T; Bridges K; Mason K; Kuban D; Mathew P; Meyn R
Radiat Oncol; 2012 Sep; 7():154. PubMed ID: 22967802
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of IL-6 expression in LNCaP prostate cancer cells by a combination of atorvastatin and celecoxib.
Wang H; Cui XX; Goodin S; Ding N; Van Doren J; Du Z; Huang MT; Liu Y; Cheng X; Dipaola RS; Conney AH; Zheng X
Oncol Rep; 2014 Feb; 31(2):835-41. PubMed ID: 24296978
[TBL] [Abstract][Full Text] [Related]
12. R115777 (Zarnestra)/Zoledronic acid (Zometa) cooperation on inhibition of prostate cancer proliferation is paralleled by Erk/Akt inactivation and reduced Bcl-2 and bad phosphorylation.
Caraglia M; Marra M; Leonetti C; Meo G; D'Alessandro AM; Baldi A; Santini D; Tonini G; Bertieri R; Zupi G; Budillon A; Abbruzzese A
J Cell Physiol; 2007 May; 211(2):533-43. PubMed ID: 17192846
[TBL] [Abstract][Full Text] [Related]
13. FAM3B/PANDER inhibits cell death and increases prostate tumor growth by modulating the expression of Bcl-2 and Bcl-X
Maciel-Silva P; Caldeira I; de Assis Santos I; Carreira ACO; Siqueira FR; Antonioli E; Goldberg AC; Belizário JE; Garay-Malpartida HM
BMC Cancer; 2018 Jan; 18(1):90. PubMed ID: 29357840
[TBL] [Abstract][Full Text] [Related]
14. Sea cucumber extract TBL-12 inhibits the proliferation, migration, and invasion of human prostate cancer cells through the p38 mitogen-activated protein kinase and intrinsic caspase apoptosis pathway.
Yuan L; Huang X; Zhou K; Zhu X; Huang B; Qiu S; Cao K; Xu L
Prostate; 2019 Jun; 79(8):826-839. PubMed ID: 30889629
[TBL] [Abstract][Full Text] [Related]
15. Myeloid cell leukemia-1 is a key molecular target for mithramycin A-induced apoptosis in androgen-independent prostate cancer cells and a tumor xenograft animal model.
Choi ES; Jung JY; Lee JS; Park JH; Cho NP; Cho SD
Cancer Lett; 2013 Jan; 328(1):65-72. PubMed ID: 23000424
[TBL] [Abstract][Full Text] [Related]
16. The preventative effects of sunitinib malate observed in the course from non-castration to castration LNCaP xenograft prostate tumors.
Jing C; Ning J; Yuanjie N
J Cancer Res Clin Oncol; 2012 Dec; 138(12):2137-43. PubMed ID: 22868821
[TBL] [Abstract][Full Text] [Related]
17. Atorvastatin induces apoptosis in vitro and slows growth of tumor xenografts but not polyp formation in MIN mice.
Huang EH; Johnson LA; Eaton K; Hynes MJ; Carpentino JE; Higgins PD
Dig Dis Sci; 2010 Nov; 55(11):3086-94. PubMed ID: 20186482
[TBL] [Abstract][Full Text] [Related]
18. Fangchinoline induced G1/S arrest by modulating expression of p27, PCNA, and cyclin D in human prostate carcinoma cancer PC3 cells and tumor xenograft.
Wang CD; Huang JG; Gao X; Li Y; Zhou SY; Yan X; Zou A; Chang JL; Wang YS; Yang GX; He GY
Biosci Biotechnol Biochem; 2010; 74(3):488-93. PubMed ID: 20208355
[TBL] [Abstract][Full Text] [Related]
19. Down-regulation of E-cadherin enhances prostate cancer chemoresistance via Notch signaling.
Wang W; Wang L; Mizokami A; Shi J; Zou C; Dai J; Keller ET; Lu Y; Zhang J
Chin J Cancer; 2017 Mar; 36(1):35. PubMed ID: 28356132
[TBL] [Abstract][Full Text] [Related]
20. Atorvastatin and Caffeine in Combination Regulates Apoptosis, Migration, Invasion and Tumorspheres of Prostate Cancer Cells.
Wang Z; Zhang L; Wan Z; He Y; Huang H; Xiang H; Wu X; Zhang K; Liu Y; Goodin S; Du Z; Zheng X
Pathol Oncol Res; 2020 Jan; 26(1):209-216. PubMed ID: 29796873
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
